| 000 | 01872 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516140113.0 | ||
| 264 | 0 | _c20130903 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0057494 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoy, Christian | |
| 245 | 0 | 0 |
_aRelationship of C5L2 receptor to skeletal muscle substrate utilization. _h[electronic resource] |
| 260 |
_bPloS one _c2013 |
||
| 300 |
_ae57494 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCell Respiration _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aExercise |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aObesity _xblood |
| 650 | 0 | 4 |
_aOxidative Phosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aReceptor, Anaphylatoxin C5a |
| 650 | 0 | 4 |
_aReceptors, Chemokine _xblood |
| 650 | 0 | 4 |
_aSubstrate Specificity _xdrug effects |
| 700 | 1 | _aPaglialunga, Sabina | |
| 700 | 1 | _aSchaart, Gert | |
| 700 | 1 | _aMoonen-Kornips, Esther | |
| 700 | 1 | _aMeex, Ruth C | |
| 700 | 1 | _aPhielix, Esther | |
| 700 | 1 | _aHoeks, Joris | |
| 700 | 1 | _aHesselink, Matthijs K C | |
| 700 | 1 | _aCianflone, Katherine | |
| 700 | 1 | _aSchrauwen, Patrick | |
| 773 | 0 |
_tPloS one _gvol. 8 _gno. 2 _gp. e57494 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0057494 _zAvailable from publisher's website |
| 999 |
_c22553471 _d22553471 |
||